Mikuláš Hrubiško

Suggest Changes
Learn More
PURPOSE Bisphosphonates have been found to reduce the incidence of skeletal-related events (SREs) in patients with multiple myeloma. This is the first double-blind, randomized, placebo-controlled(More)